About Inspira Bio-Pharm Private Limited
Data last updated:
Inspira Bio-Pharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 October 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC142898. Its GSTIN is 27AABCI1619P1ZB (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6.43 Lakh. It is led by directors including Onar Singh Sawai Singh Shekhawat and Amit Chunnilal Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 102 Marine Chambers 11 New Marine Lines Mumbai, Maharashtra, India – 400020.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.29 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹6.64 Cr (net margin 6.8%) and EBITDA of ₹9.77 Cr (EBITDA margin 10%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 11% over five years.
As per MCA filings, the company has satisfied charges of ₹3 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 1 case is pending. The company has 3 deals on record (3 secondary share transfers); the latest was in March 2022. Its 4 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 2 smaller; the largest is Antex Pharma Private Limited with revenue of ₹98.92 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 25 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ethachem.com.
Company details
Contact details
Inspira Bio-Pharm Private Limited's registered office is in Mumbai, Maharashtra. Its website is ethachem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address102 Marine Chambers 11 New Marine Lines Mumbai, Maharashtra, India – 400020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Inspira Bio-Pharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inspira Bio-Pharm is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inspira Bio-Pharm Private Limited, buy the company report.
Financials of Inspira Bio-Pharm Private Limited
FY 2025 filings availableInspira Bio-Pharm Private Limited reported revenue of ₹97.29 Cr (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.64 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10% | ||||
| Net Profit Margin | 6.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inspira Bio-Pharm Private Limited, buy the company report.
Board of directors of Inspira Bio-Pharm Private Limited
Inspira Bio-Pharm has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Onar Singh Sawai Singh Shekhawat | Director | 04 Jan 2008 | 18 Years 10 Months | Current |
| Amit Chunnilal Jain Also directs: Laxmidevi Jajodia Foundation | Director | 19 Apr 2024 | 2 Years 6 Months | Current |
| Vivek Jajodia Also directs: Laxmidevi Jajodia Foundation | Director | 28 Oct 2003 | 23 Years 0 Months | Current |
| Bhushan Pyarelal Jain Also directs: M.C.B. Sales and Services LLP | Director | 19 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Inspira Bio-Pharm Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Antex Pharma Private Limited | ₹98.92 Cr (FY 2024) | 23.0% | Delhi, India | |||
| Visa Pharmaceuticals Private Limited | ₹98.08 Cr (FY 2016) | 34.0% | Kolkata, West Bengal, India | |||
| Inspira Bio-Pharm Private Limitedthis company | ₹97.29 Cr (FY 2025) | ₹6.64 Cr | 6.8% | -17.0% | Mumbai, Maharashtra, India | |
| Vea Impex (I) Private Limited | ₹96.93 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Medico Intercontinental Limited | ₹96.37 Cr (FY 2025) | 34.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Inspira Bio-Pharm Private Limited, buy the company report.
Auditor
Inspira Bio-Pharm Private Limited is audited by V N S S & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V N S S & CO. | FY 2024 | 157451W |
Shareholding
The shareholding of Inspira Bio-Pharm Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Inspira Bio-Pharm Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2010 | 10231343 | Canara Bank | ₹3 Cr | Satisfied |
To see the full charge records of Inspira Bio-Pharm Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Inspira Bio-Pharm Private Limited has 3 deals on record (3 secondary share transfers); the latest was in March 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Seller: an individual |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Inspira Bio-Pharm Private Limited has 4 court cases on record: 4 filed by Inspira Bio-Pharm. 1 case is pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed by the company against Oyster Labs Ltd. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Ind-Swift Ltd and Ors and 2 others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Court case (SUMMARY CIVIL SUIT) | Filed by the company against Ind Swift Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against M/S. Chemipack Corporation | Disposed |
To see the full case history of Inspira Bio-Pharm Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Inspira Bio-Pharm Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Globofarm International Private Limited | |||
| Panchsheel Organics Ltd - Indore (CR) | |||
| Mehta Vet Chem (CR.) | |||
| Bhagwati Organics Private Limited | |||
| Turakhia Brothers |
To see the full MSME payment records of Inspira Bio-Pharm Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Inspira Bio-Pharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCI1619P1ZB | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Inspira Bio-Pharm Private Limited, buy the company report.
Recent activity
Inspira Bio-Pharm Private Limited has 8 board changes on record since 2003: 4 appointments and 4 cessations. The latest: Amit Chunnilal Jain ceased to be Additional Director on 29 Sep 2024.
2 earlier events are in the company report.
Frequently asked questions
Inspira Bio-Pharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 October 2003 (23+ years old) and is registered under CIN U24230MH2003PTC142898.
Inspira Bio-Pharm has 4 current directors:
- Onar Singh Sawai Singh Shekhawat - Director
- Amit Chunnilal Jain - Director
- Vivek Jajodia - Director
- Bhushan Pyarelal Jain - Director
The latest financial statements of Inspira Bio-Pharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inspira Bio-Pharm is 27AABCI1619P1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Inspira Bio-Pharm is U24230MH2003PTC142898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inspira Bio-Pharm has 4 court cases on record: 4 filed by the company. 1 is pending.
Inspira Bio-Pharm was incorporated on 28 October 2003, making it 23+ years old. It is registered with the Registrar of Companies, Mumbai.
Inspira Bio-Pharm has 3 deals on record (3 secondary share transfers); the latest was in March 2022.
The peers of Inspira Bio-Pharm by revenue are Antex Pharma Private Limited, Visa Pharmaceuticals Private Limited, Vea Impex (I) Private Limited, Medico Intercontinental Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Amit Chunnilal Jain ceased to be Additional Director on 29 Sep 2024. Bhushan Pyarelal Jain ceased to be Additional Director on 29 Sep 2024. Amit Chunnilal Jain was appointed as Director on 19 Apr 2024. Inspira Bio-Pharm has 8 board changes on record in total.
Inspira Bio-Pharm has 14 MSME Form 1 returns on record between 2019 and 2024, listing 138 overdue payments to 25 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Inspira Bio-Pharm can be reached through the website ethachem.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
